医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
一般論文
多規格が併売されている注射用抗がん剤の最適な採用戦略に関する研究
小野 尚志粟屋 敏雄都築 仁美須野 学山下 恭範大滝 康一田崎 嘉一松原 和夫
著者情報
ジャーナル フリー

2011 年 37 巻 8 号 p. 467-474

詳細
抄録

Inventory control of expensive injection drugs is highly important in hospital management, and careful handling of highrisk drugs is required to ensure safety in drug therapy. In this regard, when a hospital determines appropriate content sizes to be adopted in the case of drugs available in many different vial sizes, it is necessary to weigh costs against risk management, especially for anti-cancer drugs since they are not only expensive but also highly hazardous. Therefore, the establishment of an adoption strategy for these drugs is a prerequisite for efficient hospital management and safety of drug therapy.
This study looked at an appropriate drug size adoption strategy for anticancer chemotherapeutics at Asahikawa Medical University based the following approach: 1) determine the motives for increasing or decreasing the number of drugs purchased in multiple vial sizes, 2) examine the expected effects of each motive, 3) determine the greatest effect by evaluation of drug properties, 4) in evaluation obtain score for each property and 5) determine appropriate adoption priority indices. A review of the vial sizes adopted based on this approach showed that it would reduce patient co-payments as well as hospital expenses without compromising safety or operational procedures.
Therefore, an effective drug adoption strategy based on individual drug characteristics and available sizes could achieve greater safety and efficiency in hospital management.

著者関連情報
© 2011 日本医療薬学会
前の記事 次の記事
feedback
Top